Dr. Ivetta Danylesko is an attending physician at the BMT Unit of Hematooncology Division.
She has completed with honor her medical education at the Georgievsky Crimia State Medical University in 1997. Then she specialized in Infectious Diseases. She has completed her clinical fellowship and lectured at the Department of Infectious Diseases.
Dr. Danylesko repatriated to Israel in 2001. After her repatriation she specialized in Internal Medicine and Hematology.
Dr. Danylesko actively participates in international EHA, EBMT and ASH congresses.
Dr. Danylesko publishes in scientific journals and lectures to students. She was awarded the title of lecturer at Tel Aviv University in 2017. As for now she is trying to achieve the title of senior lecturer.
- Leading physician at the BMT Unit
- Lecturer at Sackler Medical School of the Tel Aviv University
Conditions and treatment
Education and Training
- Completed with honor her medical education at the Georgievsky Crimia State Medical University
- Specialized in Infectious Diseases, the Georgievsky Crimia State Medical University
- Clinical fellowship at the Department of Infectious Diseases, the Georgievsky Crimia State Medical University
- Specialized in Internal Medicine and Hematology
- Internal medicine
- Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease.Danylesko I, Bukauskas A, Paulson M, Peceliunas V, Gedde-Dahl D Y T, Shimoni A, Shouval R, Griskevicius L, Floisand Y, Nagler A.
- The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation. Fein JA, Shimoni A, Labopin M, Shem-Tov N, Yerushalmi R, Magen H, Furie N, Kopel E, Danylesko I, Nagler A, Shouval R.
- Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality. Shouval R, de Jong CN, Fein J, Broers AEC, Danylesko I, Shimoni A, Reurs MR, Baars AE, van der Schaft N, Nagler A, Cornelissen JJ.